[144] Equifax, Incorporated SEC Filing
Form 144 notice for Equifax, Inc. (EFX) reporting a proposed sale of 3,764 common shares with an aggregate market value of $964,649.84 to be sold on 08/22/2025 through Fidelity Brokerage Services LLC on the NYSE. The filing lists acquisition details for these shares as an option granted on 02/09/2024 with an acquisition date recorded as 08/22/2025 and payment in cash. An additional 1 share was acquired via dividend reinvestment on 06/12/2025. The filing also discloses a sale by Todd M. Horvath of 8,797 common shares on 08/20/2025 yielding $2,199,425.94. The notice includes the required representation that the seller does not possess undisclosed material adverse information about the issuer.
Avviso Form 144 per Equifax, Inc. (EFX) che segnala la proposta di vendita di 3.764 azioni ordinarie per un valore complessivo di $964.649,84, da effettuarsi il 22/08/2025 tramite Fidelity Brokerage Services LLC alla NYSE. La comunicazione riporta che queste azioni sono state acquisite come opzione concessa il 09/02/2024, con data di acquisizione indicata il 22/08/2025 e pagamento in contanti. Una azione aggiuntiva 猫 stata ottenuta tramite reinvestimento dei dividendi il 12/06/2025. Il documento segnala inoltre la vendita da parte di Todd M. Horvath di 8.797 azioni ordinarie il 20/08/2025, per un controvalore di $2.199.425,94. L'avviso contiene la dichiarazione richiesta che il venditore non 猫 in possesso di informazioni materiali non divulgate sull'emittente.
Aviso Formulario 144 para Equifax, Inc. (EFX) que informa sobre la propuesta de venta de 3.764 acciones ordinarias por un valor agregado de $964.649,84, a venderse el 22/08/2025 a trav茅s de Fidelity Brokerage Services LLC en la NYSE. El informe indica que estas acciones fueron adquiridas como una opci贸n concedida el 09/02/2024, con fecha de adquisici贸n registrada el 22/08/2025 y pago en efectivo. Una acci贸n adicional se obtuvo mediante reinversi贸n de dividendos el 12/06/2025. El documento tambi茅n revela la venta por parte de Todd M. Horvath de 8.797 acciones ordinarias el 20/08/2025, por un importe de $2.199.425,94. El aviso incluye la representaci贸n requerida de que el vendedor no posee informaci贸n material no divulgada sobre el emisor.
Equifax, Inc. (EFX)鞐� 雽�頃� Form 144 韱奠搿�, $964,649.84鞚� 齑� 鞁滉皜毳� 臧�歆� 3,764 氤错喌欤茧ゼ 2025-08-22鞐� NYSE鞐愳劀 Fidelity Brokerage Services LLC毳� 韱淀暣 毵る弰頃� 鞓堨爼鞚措澕瓿� 氤搓碃頃橁碃 鞛堨姷雼堧嫟. 靹滊鞐愲姅 頃措嫻 欤检嫕鞚� 2024-02-09鞐� 攵�鞐悳 鞓奠厴鞙茧 須嶋摑霅橃棃瓿�, 旆摑鞚检澊 2025-08-22搿� 旮办灛霅橃棃鞙茧┌ 雽�旮堨潃 顺勱笀鞙茧 歆�旮夒悳雼り碃 旮办灛霅橃柎 鞛堨姷雼堧嫟. 於旉皜搿� 1欤缄皜 2025-06-12鞐� 氚半嫻旮� 鞛埇鞛�毳� 韱淀暣 旆摑霅橃棃鞀惦媹雼�. 靹滊電� 霕愴暅 Todd M. Horvath臧� 2025-08-20鞐� 8,797欤茧ゼ 毵る弰頃橃棳 $2,199,425.94毳� 瓯半憯 靷嫟鞚� 瓿店皽頃橁碃 鞛堨姷雼堧嫟. 韱奠靹滌棎電� 毵る弰鞚胳澊 氚滍枆靷棎 雽�頃� 瓿店皽霅橃 鞎婌潃 欷戩殧 鞝曤炒毳� 氤挫湢頃橁碃 鞛堨 鞎婋嫟電� 頃勳垬 歆勳垹霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Avis du formulaire 144 concernant Equifax, Inc. (EFX) signalant une proposition de vente de 3鈥�764 actions ordinaires pour une valeur totale de 964鈥�649,84 $, qui doit 锚tre r茅alis茅e le 22/08/2025 via Fidelity Brokerage Services LLC sur le NYSE. Le d茅p么t indique que ces actions ont 茅t茅 acquises au titre d'une option accord茅e le 09/02/2024, avec une date d'acquisition enregistr茅e au 22/08/2025 et un paiement en 别蝉辫猫肠别蝉. Une action suppl茅mentaire a 茅t茅 obtenue par r茅investissement de dividendes le 12/06/2025. Le document divulgue 茅galement la vente par Todd M. Horvath de 8鈥�797 actions ordinaires le 20/08/2025, pour un produit de 2鈥�199鈥�425,94 $. L'avis inclut la d茅claration requise selon laquelle le vendeur ne d茅tient pas d'informations mat茅rielles non divulgu茅es concernant l'茅metteur.
Form 144-Mitteilung f眉r Equifax, Inc. (EFX), die einen geplanten Verkauf von 3.764 Stammaktien mit einem Gesamtkurswert von $964.649,84 meldet, der am 22.08.2025 眉ber Fidelity Brokerage Services LLC an der NYSE erfolgen soll. Die Meldung f眉hrt aus, dass diese Aktien durch eine Option, die am 09.02.2024 gew盲hrt wurde, erworben wurden, mit einem eingetragenen Erwerbsdatum am 22.08.2025 und Zahlung in Bargeld. Eine weitere Aktie wurde durch Dividendenreinvestition am 12.06.2025 erworben. Die Einreichung legt au脽erdem den Verkauf von 8.797 Stammaktien durch Todd M. Horvath am 20.08.2025 offen, der $2.199.425,94 einbrachte. Die Mitteilung enth盲lt die erforderliche Erkl盲rung, dass der Verk盲ufer keine nicht offenbarten wesentlichen Informationen 眉ber den Emittenten besitzt.
- Disclosure compliance: Filing provides required Rule 144 details including broker, number of shares, market value, and planned sale date.
- Transaction transparency: Acquisition dates, nature of acquisition (option granted and dividend reinvestment), and payment method (cash) are documented.
- Seller attestation: Seller represents no undisclosed material adverse information, meeting the attestation requirement.
- Insider selling activity: Proposed sale of 3,764 shares valued at $964,649.84 and a prior sale of 8,797 shares for $2,199,425.94 indicate insider liquidity events that investors may view as material.
- Concentrated prior sale: Recent sale by Todd M. Horvath of 8,797 shares on 08/20/2025 generated substantial gross proceeds ($2,199,425.94).
Insights
TL;DR: Routine insider sale disclosure showing a modest block of shares for sale; prior recent sale also disclosed.
The filing transparently reports a proposed Rule 144 sale of 3,764 Equifax common shares valued at $964,649.84, to occur on 08/22/2025 via Fidelity on the NYSE. Acquisition details list these shares as tied to an option granted on 02/09/2024 with cash payment on 08/22/2025, and a separate 1-share dividend reinvestment on 06/12/2025. The filing also records a recent sale by Todd M. Horvath of 8,797 shares on 08/20/2025 for $2,199,425.94. This is a standard Rule 144 disclosure; it provides necessary transparency about insider sales and prior sales volumes and proceeds.
TL;DR: Disclosure meets Rule 144 mechanics; indicates insider liquidity but no assertion of undisclosed adverse information.
The notice includes the seller's attestation that no material nonpublic adverse information is held, and identifies the broker (Fidelity Brokerage Services LLC) and planned trading venue (NYSE). It documents the nature and dates of acquisition, including option-related acquisition and dividend reinvestment, and discloses a sizable recent sale by an individual (Todd M. Horvath). From a governance perspective, the filing satisfies routine public-disclosure requirements for insider sales under the Securities Act.
Avviso Form 144 per Equifax, Inc. (EFX) che segnala la proposta di vendita di 3.764 azioni ordinarie per un valore complessivo di $964.649,84, da effettuarsi il 22/08/2025 tramite Fidelity Brokerage Services LLC alla NYSE. La comunicazione riporta che queste azioni sono state acquisite come opzione concessa il 09/02/2024, con data di acquisizione indicata il 22/08/2025 e pagamento in contanti. Una azione aggiuntiva 猫 stata ottenuta tramite reinvestimento dei dividendi il 12/06/2025. Il documento segnala inoltre la vendita da parte di Todd M. Horvath di 8.797 azioni ordinarie il 20/08/2025, per un controvalore di $2.199.425,94. L'avviso contiene la dichiarazione richiesta che il venditore non 猫 in possesso di informazioni materiali non divulgate sull'emittente.
Aviso Formulario 144 para Equifax, Inc. (EFX) que informa sobre la propuesta de venta de 3.764 acciones ordinarias por un valor agregado de $964.649,84, a venderse el 22/08/2025 a trav茅s de Fidelity Brokerage Services LLC en la NYSE. El informe indica que estas acciones fueron adquiridas como una opci贸n concedida el 09/02/2024, con fecha de adquisici贸n registrada el 22/08/2025 y pago en efectivo. Una acci贸n adicional se obtuvo mediante reinversi贸n de dividendos el 12/06/2025. El documento tambi茅n revela la venta por parte de Todd M. Horvath de 8.797 acciones ordinarias el 20/08/2025, por un importe de $2.199.425,94. El aviso incluye la representaci贸n requerida de que el vendedor no posee informaci贸n material no divulgada sobre el emisor.
Equifax, Inc. (EFX)鞐� 雽�頃� Form 144 韱奠搿�, $964,649.84鞚� 齑� 鞁滉皜毳� 臧�歆� 3,764 氤错喌欤茧ゼ 2025-08-22鞐� NYSE鞐愳劀 Fidelity Brokerage Services LLC毳� 韱淀暣 毵る弰頃� 鞓堨爼鞚措澕瓿� 氤搓碃頃橁碃 鞛堨姷雼堧嫟. 靹滊鞐愲姅 頃措嫻 欤检嫕鞚� 2024-02-09鞐� 攵�鞐悳 鞓奠厴鞙茧 須嶋摑霅橃棃瓿�, 旆摑鞚检澊 2025-08-22搿� 旮办灛霅橃棃鞙茧┌ 雽�旮堨潃 顺勱笀鞙茧 歆�旮夒悳雼り碃 旮办灛霅橃柎 鞛堨姷雼堧嫟. 於旉皜搿� 1欤缄皜 2025-06-12鞐� 氚半嫻旮� 鞛埇鞛�毳� 韱淀暣 旆摑霅橃棃鞀惦媹雼�. 靹滊電� 霕愴暅 Todd M. Horvath臧� 2025-08-20鞐� 8,797欤茧ゼ 毵る弰頃橃棳 $2,199,425.94毳� 瓯半憯 靷嫟鞚� 瓿店皽頃橁碃 鞛堨姷雼堧嫟. 韱奠靹滌棎電� 毵る弰鞚胳澊 氚滍枆靷棎 雽�頃� 瓿店皽霅橃 鞎婌潃 欷戩殧 鞝曤炒毳� 氤挫湢頃橁碃 鞛堨 鞎婋嫟電� 頃勳垬 歆勳垹霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Avis du formulaire 144 concernant Equifax, Inc. (EFX) signalant une proposition de vente de 3鈥�764 actions ordinaires pour une valeur totale de 964鈥�649,84 $, qui doit 锚tre r茅alis茅e le 22/08/2025 via Fidelity Brokerage Services LLC sur le NYSE. Le d茅p么t indique que ces actions ont 茅t茅 acquises au titre d'une option accord茅e le 09/02/2024, avec une date d'acquisition enregistr茅e au 22/08/2025 et un paiement en 别蝉辫猫肠别蝉. Une action suppl茅mentaire a 茅t茅 obtenue par r茅investissement de dividendes le 12/06/2025. Le document divulgue 茅galement la vente par Todd M. Horvath de 8鈥�797 actions ordinaires le 20/08/2025, pour un produit de 2鈥�199鈥�425,94 $. L'avis inclut la d茅claration requise selon laquelle le vendeur ne d茅tient pas d'informations mat茅rielles non divulgu茅es concernant l'茅metteur.
Form 144-Mitteilung f眉r Equifax, Inc. (EFX), die einen geplanten Verkauf von 3.764 Stammaktien mit einem Gesamtkurswert von $964.649,84 meldet, der am 22.08.2025 眉ber Fidelity Brokerage Services LLC an der NYSE erfolgen soll. Die Meldung f眉hrt aus, dass diese Aktien durch eine Option, die am 09.02.2024 gew盲hrt wurde, erworben wurden, mit einem eingetragenen Erwerbsdatum am 22.08.2025 und Zahlung in Bargeld. Eine weitere Aktie wurde durch Dividendenreinvestition am 12.06.2025 erworben. Die Einreichung legt au脽erdem den Verkauf von 8.797 Stammaktien durch Todd M. Horvath am 20.08.2025 offen, der $2.199.425,94 einbrachte. Die Mitteilung enth盲lt die erforderliche Erkl盲rung, dass der Verk盲ufer keine nicht offenbarten wesentlichen Informationen 眉ber den Emittenten besitzt.
FAQ
What does Equifax's (EFX) Form 144 filed here report?
Who is the broker and on which exchange will the EFX shares be sold?
What acquisition information is disclosed for the shares to be sold?
Did the filer report any sales of Equifax shares in the past three months?
Does the filing state whether the seller has undisclosed adverse information about Equifax?
